Recent Updates
Recently added Catalysts
BHST Positive Sentiment Score: 70/100

MATERIAL CHANGE REPORT DATED SEPTEMBER 9 , 2025 Material Change Report dated September 9 , 2025 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1. Name and Address of Company BIOHARVEST SCIENCES INC. Suite 1140 - 625 Howe Stre

Monday, September 8, 2025 2 min read
Key Takeaway: BioHarvest Sciences Inc. has announced the filing and effectiveness of a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission. This registration allows the company to offer and sell up to USD $100 million of its securities, which includes common shares and warrants, depending on market conditions and capital needs. The company emphasizes that this registration does not guarantee any specific amount will be sold and remains at its discretion based on the market environment.

Market Sentiment Analysis

POSITIVE FACTORS

  • The company has filed a shelf registration statement, indicating a proactive approach to raising capital.
  • The availability of up to USD $100 million in common shares, warrants and units could enhance financial flexibility.
  • This move may attract investor interest and strengthen market positioning.

Full Press Release Details

MATERIAL CHANGE REPORT
Item 1.Name and Address of Company
BIOHARVEST SCIENCES INC.
Suite 1140 - 625 Howe Street
Vancouver, BC, V6C 2T6
(the "Company" or "BioHarvest")
Item 2.Date of Material Change
The news release (the "News Release") was issued on September 8, 2025 and disseminated by Stockwatch.
Item 4.Summary of Material Change
The Company announced the filing and effectiveness of a shelf registration statement on Form F-3 with the U.S. Securities and Exchange Commission.
Item 5.Full Description of Material Change
The Company announced the filing and effectiveness of a shelf registration statement (the "Shelf Registration") on Form F-3 with the U.S. Securities and Exchange Commission ("SEC").
The Shelf Registration will allow the Company to offer and sell, from time to time, up to an aggregate of USD $100 million of its common shares, warrants and units, or a combination thereof (together, the "Securities"), on a registered basis, subject to market conditions, the Company's capital needs, and limitations imposed by SEC rules and applicable securities laws. The terms of any offering, including the price of Securities, will be determined at the time of such offering and be described in a prospectus supplement that will be filed with the SEC.
The Shelf Registration does not constitute a commitment by the Company to sell any specific amount of Securities. Any further offering under the Shelf Registration, if made, will be subject to the Company's discretion and applicable market conditions.
The news release issued on September 8, 2025 shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the Securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under applicable securities laws.
Item 6.Reliance on Subsection 7.1(2) of National Instrument 51-102
Item 7.Omitted Information
Item 8.Executive Officer
For further information, please contact:
Secretary and VP, Investor Relations
Item 9.Date of Report

Frequently Asked Questions

What company issued the material change report?

The material change report was issued by BioHarvest Sciences Inc.

When was the news release published?

The news release was published on September 8, 2025.

What does the shelf registration statement allow?

It allows the company to sell up to USD $100 million of its securities.

Is there a commitment to sell specific securities?

No, there is no commitment to sell any specific amount of securities.

Who can be contacted for more information?

The Secretary and VP of Investor Relations can be contacted for more details.

Tags: BHST Viatris Investor Conferences Healthcare BioHarvest Sciences shelf registration Form F-3 U.S. Securities and Exchange Commission
Last updated: Sep 8, 2025